MPS’ wholly owned material subsidiary -- MPS North America LLC (MPS NA LLC), USA, has planned to acquire 100% stake in Unbound Medicine, Inc., a United States-based healthcare technology and medical information company, subject to the terms and conditions set out in the Stock Purchase Agreement and other definitive transaction documents.
The acquisition represents a strategic milestone for MPS, marking its entry into the healthcare and medical information technology segment, a high-growth and knowledge-intensive vertical adjacent to MPS’ core strengths in digital publishing, learning platforms, and technology-enabled content solutions.
The proposed transaction is aligned with MPS’ long-term growth strategy of building platform-led, recurring-revenue businesses and is expected to complement MPS’ existing capabilities in digital content, platform engineering, and technology-enabled knowledge services. The acquisition is also expected to support long-term value creation through revenue diversification, cross-selling opportunities, AI-driven innovation, and a deeper presence in the North American market, which remains a key strategic geography for the company.
MPS is a premier learning and platform solutions provider operating at the intersection of content, technology, and artificial intelligence.
